UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ministry issues guide on safe self-injection
by Shim Hyun-tai
2020-06-12 16:37
Researchers find potential protein for brain disorder drug
by Shim Hyun-tai
2020-06-12 16:37
Over half of ‘coronavirus heroes’ feel treated unfairly: survey
by Song Soo-youn
2020-06-12 16:10
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
by Lee Han-soo
2020-06-12 16:07
Takeda’s sell-off of primary care biz to Celltrion triggers union protest
by Lee Han-soo
2020-06-12 15:32
라인
Dementia drug choline alfoscerate to get limited insurance benefit
by Kim Eun-young
2020-06-12 14:40
Social distancing extends indefinitely in greater Seoul amid sporadic eruptions
by Lee Han-soo
2020-06-12 12:08
Immunotherapies potent on rare small-cell lung cancer, biliary tract cancer
by Kim Yun-mi
2020-06-12 12:03
‘Special bank will manage, distribute food poisoning bacteria’
by Shim Hyun-tai
2020-06-11 17:56
GC LabCell releases clinical results of NK cell therapy
by Shim Hyun-tai
2020-06-11 17:34
라인
Genexine to start P1 trial of Covid-19 treatment in US
by Lee Han-soo
2020-06-11 16:26
Seoul unveils roadmap to make “K-quarantine” global standard
by Shim Hyun-tai
2020-06-11 16:20
40 patents for Covid-19 testing technologies registered in 4 months
by Choi Gwang-seok
2020-06-11 15:55
GC Wellbeing files patent for antiviral compound
by Shim Hyun-tai
2020-06-11 14:32
MSD Korea’s trade union refuses to use controversial monitoring program
by Kim Yun-mi
2020-06-11 14:31
라인
Greater Seoul remains hot spot of Covid-19 infections
by Lee Han-soo
2020-06-11 12:08
‘Drugmakers’ support for on-line academic meets, not illegal rebate’
by Kwak Sung-sun
2020-06-11 11:25
Korea shares experience of Covid-19 response in 12-nation meeting
by Shim Hyun-tai
2020-06-10 17:59
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
by Lee Han-soo
2020-06-10 17:58
Myongji Hospital to develop AI-based Covid-19 detection kit in 3-way project
by Lee Han-soo
2020-06-10 16:07
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top